← Return to My experience in High Risk MGUS & Non High Risk SMM trial
DiscussionMy experience in High Risk MGUS & Non High Risk SMM trial
Blood Cancers & Disorders | Last Active: 2 days ago | Replies (9)Comment receiving replies
Replies to "I never heard of high risk MGUS either. My numbers certainly exceed or equal yours (also..."
Connect

@hsminc
Linvoseltamab is a FDA approved immunotherapy drug used to treat relapsed or refractory multiple myeloma. Approved for adults who have already received at least four prior therapy lines. Clinical trial is to see if it can delay progression.
I believe I am intermediate SMM because my kappa lambda free light chain ratio is greater than 20. My plasma cell percentage is 10-15 % and my FISH panel showed gain of 1Q and monosomy 13 which apparently puts me on a faster track to progression.
I am cautiously optomistic.